End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.67 CNY | -0.73% | +2.31% | +50.03% |
05-13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
04-25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Official Publications